It is well established that patients with diabetes demonstrate higher susceptibility to pancreatic cancer and pancreatitis compared to non-diabetic individuals, and theoretically, sustained GLP-1 receptor activation induced by GLP-1RA therapy may potentially elevate pancreatic cancer risk [8]
But in the last few years, there's been a new player in the mixpeptides, and everyone seems to be talking about them
Conclusion: Making Informed Decisions About Semaglutide Therapy Semaglutides side effect profile is well-characterized through extensive clinical trial data involving over 11,000 participants in the SUSTAIN and PIONEER programs, thousands more in the STEP weight management trials, and ongoing real-world surveillance
When to seek urgent medical attention : Severe, persistent abdominal pain that does not resolve (if pancreatitis is suspected, stop taking the medication and seek immediate medical assessment) Signs of dehydration from persistent vomiting or diarrhoea (which can lead to acute kidney injury) Allergic reactions (rash, difficulty breathing, swelling of face or throat) Symptoms of hypoglycaemia if taking other glucose-lowering medications (shakiness, confusion, sweating) Regular follow-up with your healthcare team is essential to monitor your response to treatment, adjust doses appropriately, and address any concerns promptly
The medication appears to affect the brain's reward pathways, potentially diminishing the pleasure response associated with certain foods, though this evidence is still developing
Mercaptopropionylglycine is used in the treatment of cystinuria, a rare autoimmune condition characterized by excessive occurrence of cystine in urine, resulting in the formation of cystine stones in the urinary tract